ON-DEMAND WEBINARS

Using volatile processing aids to increase drug solubility in more environmentally friendly solvents, like methanol, reduces the amount of solvent required to manufacture amorphous solid dispersions (ASDs).

Learn about new data on nanotechnology formulations for multiple dose forms and routes of delivery, including oral, long-acting injectables, inhalation, and ophthalmic.

By reducing the size of drug particles, nanoforming offers new opportunities — from increased bioavailability to sustained drug delivery. Discover the potential benefits supported by case studies.

Learn about key product parameters affecting patient acceptability and therapy adherence and taste masking strategies, including organoleptic and barrier coating approaches and microencapsulation technologies.

ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

Tom von Gunden, Chief Editor & Community Director, Drug Delivery Leader

Tom hosts multiple videocast series providing expert takes and insider perspectives on drug delivery:

Talk to Tom today!


Fran DeGrazio, Executive Editor - Drug Delivery Leader & Frankly Fran

In her monthly column, Fran offers keen industry insights exclusively on Drug Delivery Leader.

FRANKLY FRAN

  • In this article, Fran DeGrazio recounts the evolution of drug delivery technologies as she underscores the need to innovate in the delivery of advanced therapies. Considering chronic diseases, rare diseases, and difficult-to-reach therapeutic targets, Fran offers suggestions for organizing and readying for the development and delivery of platforms, systems, and devices for next generation treatments, including personalized, precision medicines.

FREE EBOOK: COMBINATION PRODUCTS

Combination products provide significant avenues for increasing patient adherence and overall efficacy. This collection outlines the opportunity and identifies strategies for gaining regulatory approval.